| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_532859d9c7e8b89e4d0877f7535bda90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ed350b9be1198ccb5ed528ed8cd00f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_648848962f39ce04957cc293bc2c8dc5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409 |
| filingDate |
2002-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e480fe3cc867412351b6d2da0e8ab1b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e65d00aa89aff9d950a67c8e0e9522 |
| publicationDate |
2003-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03015825-A2 |
| titleOfInvention |
Conjugate |
| abstract |
The present invention relates to a polypeptide comprising at least one alpha-helix having synthetically attached thereto a plurality of therapeutic or diagnostic moieties, wherein said therapeutic or diagnostic moieties may be the same or different and are spatially oriented on the polypeptide so as to minimise interactions between said moieties. Further aspects of the invention relate to a pharmaceutical composition comprising the polypeptide; a polynucleotide sequence encoding the polypeptide; an expression vector comprising said polynucleotide sequence; and a host cell transformed with said expression vector. The invention also provides a method of treatment comprising administering to a subject in need thereof a therapeutically effective amount of said polypeptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703427-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2563379-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2563379-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007042775-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011134075-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202837-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010106341-A1 |
| priorityDate |
2001-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |